It has been shown previously that LD-IL-2 can enhance the functions of CD8+ T cells and NK cells, both of which are required to mount immune responses against infections.21,42,43 The effects of LD-IL-2 therapy on CD8+ T cells and NK cells should be specifically addressed in future studies. Here, CD8A is linked to infection.